Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype

Jianxin Jiang; Chao Yu; Meiyuan Chen; Hao Zhang; Se Tian; Chengyi Sun

doi:10.18632/oncotarget.3089

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype

Jianxin Jiang, Chao Yu, Meiyuan Chen, Hao Zhang, Se Tian and Chengyi Sun _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:2767-2778. https://doi.org/10.18632/oncotarget.3089

Metrics: PDF 2575 views | HTML 2518 views | ?

Abstract

Jianxin Jiang1, Chao Yu1, Meiyuan Chen1, Hao Zhang1, Se Tian1 and Chengyi Sun1

1 Department of Hepatobiliary Surgery, Affiliated Hospital of Guiyang Medical College, Guiyang, Guizhou, China

Correspondence:

Chengyi Sun, email:

Keywords: Pancreatic cancer, miR-29c, Wnt, FRAT2, LRP6

Received: October 30, 2014 Accepted: December 25, 2014 Published: December 30, 2014

Abstract

The hallmarks of pancreatic cancer are limitless replicative potential as well as tissue invasion and metastasis, leading to an extremely aggressive disease with shockingly high lethality. However, the molecular mechanisms underlying these characteristics remain largely unclear. Herein, we report the results of a differential miRNA expression screen that compared pancreatic cancer tissues and normal pancreatic tissues, where the pancreatic cancer tissues had highly downregulated miR-29c with relative Wnt cascade hyperactivation. MiR-29c directly suppressed the following Wnt upstream regulators: frequently rearranged in advanced T-cell lymphomas 2 (FRAT2), low-density lipoprotein receptor–related protein 6 (LRP6), Frizzled-4 (FZD4) and Frizzled-5 (FZD5). Furthermore, transforming growth factor-β (TGF-β) inhibited miR-29c expression, leading to Wnt activation. Significantly, our results were consistent with an important correlation between miR-29c levels and TGF-β hyperactivation and the activated Wnt cascade in human pancreatic cancer specimens. These findings reveal a novel mechanism for Wnt hyperactivation in pancreatic cancer and may suggest a new target for clinical intervention in pancreatic cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3089

Publication Alerts

Research Papers:

Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype

Abstract